Skip to main content

A novel phytosphingosine based 1-O-Acyiceramide – Webinar 3 May



Join us for more top notch science from the London Congress on 3 May. We’ve invited Dr Chang Seo Park of LCS Biotech (Korea) to give his Top 10 Poster from the London 2022 Congress. He’ll be sharing his paper –  A novel phytosphingosine based 1-O-Acyiceramide: synthesis, physiochemical characterization and role in the lipid lamellar organization – live from Suppliers Day in New York City so we’ll be at our usual time of 11h NYC.

The research that will be presented is the first report on the development of a novel 1-O-Acylceramides, specifically 1-O-Stearoyl-ceramide NP. Based on the molecular structure of 1-O-Stearoyl-ceramide NP, the researchers postulated that it might play a critical role in stabilizing the SC multilamellar organization through bidirectional anchoring neighboring lipid lamellars.


Times 8h West Coast USA • 9h Mexico City • 10h Chicago/Bogotá • 11h East Coast USA • 12h Sao Paolo UK • 16h London • 17h Central Europe/South Africa • 18h Tel Aviv • 20h30 New Delhi • 23h Singapore/HK/China/Taipei • 0h Korea/Japan • Thursday 1h Melbourne • 3h Wellington

Dr Chang Seo Park is the CTO of LCS Biotech. He got his Ph.D. in Microbiology at UC Davis, USA. He started his career at Doosan Biotech in 1981 where he developed ceramide production processes based on yeast-derived phytosphingosine. Then moved to Dongguk University’s chemical and biochemical engineering department in Seoul, Korea, where he focused on skin barrier research.​​​​ He joined LCS Biotech in 2007 as a co-founder and was involved in developing eco-friendly ceramide products including EcoCeramide LCS and EcoCeramide ENP.